A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome

British Journal of Nutrition

Volumn 109, Issue 5, 2013, Pages 810-815

  Auinger, A ^a   Rubin, D ^a,b,c   Sabandal, M ^a   Helwig, U ^a,b   Ruther A ^d   Schreiber, S ^d   Foelsch, U R ^b   Doring F ^d   Schrezenmeir, J ^a,b  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

Carnitine palmitoyltransferase; Cholesterol; Metabolic syndrome; Polymorphisms; TAG

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1B; GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASPARTATE AMINOTRANSFERASES; CARNITINE O-PALMITOYLTRANSFERASE; FASTING; FATTY LIVER; GAMMA-GLUTAMYLTRANSFERASE; GENOTYPE; GLUCOSE TOLERANCE TEST; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84874672042     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512002656     Document Type: Article

References (23)

1. Bonnefont J-P, Djouadi F, Prip-Buus C, et al. (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25, 495-520.
2. Robitaille J, Houde A, Lemieux S, et al. (2007) Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians. J Mol Med 85, 129-137.
3. Miljkovic I, Yerges LM, Li H, et al. (2009) Association of the CPT1B gene with skeletal muscle fat infiltration in Afro-Caribbean men. Obesity 17, 1396-1401.
4. Levy D, Garrison RJ, Savage DD, et al. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322, 1561-1566.
5. Alberti KG, Zimmet P & Shaw J (2006) Metabolic syndrome-A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23, 469-480.
6. Rubin D, Helwig U, Nothnagel M, et al. (2010) Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel (MICK). Eur J Endocrinol 162, 719-727.
7. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
8. Mari A, Pacini G, Murphy E, et al. (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24, 539-548.
9. Bedogni G, Bellentani S, Miglioli L, et al. (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6, 33-39.
10. Hampe J, Shaw SH, Saiz R, et al. (1999) Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 65, 1647-1655.
11. Barrett JC, Fry B, Maller J, et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
12. Li SS, Khalid N, Carlson C, et al. (2003) Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 4, 513-522.
13. Tanaka T, Yamamoto J, Iwasaki S, et al. (2003) Activation of peroxisome proliferator-Activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100, 15924-15929.
14. Vedala A, Wang W, Neese RA, et al. (2006) Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J Lipid Res 47, 2562-2574.
15. Dobbins RL, Szczepaniak LS, Bentley B, et al. (2001) Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50, 123-130.
16. Bruce CR, Hoy AJ, Turner N, et al. (2009) Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58, 550-558.
17. Perdomo G, Commerford SR, Richard AM, et al. (2004) Increased beta-oxidation in muscle cells enhances insulinstimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 279, 27177-27186.
18. Kim JK, Michael MD, Previs SF, et al. (2000) Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105, 1791-1806.
19. Petersen KF, Dufour S, Savage DB, et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104, 12587-12594.
20. Yamazaki N, Matsuo T, Kurata M, et al. (2008) Substitutions of three amino acids in human heart/muscle type carnitine palmitoyltransferase I caused by single nucleotide polymorphisms. Biochem Genet 46, 54-63.
21. Kraja AT (2010) Metabolic syndrome-modern pharmacological, genetic, clinical and environmental contributions. Endocr Metab Immune Disord Drug Targets 10, 84-85.
22. Zabaneh D & Balding DJ (2010) A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One 5, e11961.
23. Pearson TA & Manolio TA (2008) How to interpret a genomewide association study? JAMA 299, 1335-1344.